应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
DSGN Design Therapeutics, Inc.
休市中 08-16 16:00:00 EDT
4.45
+0.16
+3.73%
盘后
4.45
+0.00
0.00%
16:02 EDT
最高
4.54
最低
4.24
成交量
8.27万
今开
4.28
昨收
4.29
日振幅
6.99%
总市值
2.52亿
流通市值
1.09亿
总股本
5,662万
成交额
36.60万
换手率
0.34%
流通股本
2,442万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Design Therapeutics, Inc.盘中异动 下午盘股价大涨5.83%报4.54美元
自选股智能写手 · 08-17 01:01
Design Therapeutics, Inc.盘中异动 下午盘股价大涨5.83%报4.54美元
Design Therapeutics, Inc.盘中异动 股价大涨5.45%报4.45美元
自选股智能写手 · 08-15 22:57
Design Therapeutics, Inc.盘中异动 股价大涨5.45%报4.45美元
Design Therapeutics, Inc.盘中异动 早盘快速上涨5.42%报4.28美元
自选股智能写手 · 08-09
Design Therapeutics, Inc.盘中异动 早盘快速上涨5.42%报4.28美元
Design Therapeutics, Inc.盘中异动 下午盘急速上涨5.33%
自选股智能写手 · 08-09
Design Therapeutics, Inc.盘中异动 下午盘急速上涨5.33%
Design Therapeutics公司:Leerink Partners将目标价从4.00美元上调至5.00美元。
智通财经 · 08-06
Design Therapeutics公司:Leerink Partners将目标价从4.00美元上调至5.00美元。
Design Therapeutics(DSGN.US):2024年Q2财报实现营收0美元,前值为0美元;每股收益为-0.
智通财经 · 08-05
Design Therapeutics(DSGN.US):2024年Q2财报实现营收0美元,前值为0美元;每股收益为-0.
Design Therapeutics:截至2024年6月30日的现金、现金等价物和可变现证券预计可支持其计划的营业费用直至2029年。
智通财经 · 08-05
Design Therapeutics:截至2024年6月30日的现金、现金等价物和可变现证券预计可支持其计划的营业费用直至2029年。
Design Therapeutics, Inc.盘中异动 早盘股价大跌8.12%
自选股智能写手 · 08-02
Design Therapeutics, Inc.盘中异动 早盘股价大跌8.12%
Design Therapeutics, Inc.盘中异动 快速上涨5.23%报5.03美元
自选股智能写手 · 07-26
Design Therapeutics, Inc.盘中异动 快速上涨5.23%报5.03美元
Design Therapeutics, Inc.盘中异动 早盘急速拉升5.19%报4.26美元
自选股智能写手 · 07-24
Design Therapeutics, Inc.盘中异动 早盘急速拉升5.19%报4.26美元
Design Therapeutics, Inc.盘中异动 临近午盘股价大跌5.38%报4.22美元
自选股智能写手 · 07-18
Design Therapeutics, Inc.盘中异动 临近午盘股价大跌5.38%报4.22美元
Design Therapeutics, Inc.盘中异动 股价大涨5.02%报4.71美元
自选股智能写手 · 07-16
Design Therapeutics, Inc.盘中异动 股价大涨5.02%报4.71美元
Design Therapeutics, Inc.盘中异动 早盘快速上涨5.66%报4.48美元
自选股智能写手 · 07-12
Design Therapeutics, Inc.盘中异动 早盘快速上涨5.66%报4.48美元
Design Therapeutics, Inc.盘中异动 股价大涨5.25%报3.81美元
自选股智能写手 · 07-11
Design Therapeutics, Inc.盘中异动 股价大涨5.25%报3.81美元
Design Therapeutics, Inc.盘中异动 急速下跌5.46%
自选股智能写手 · 06-13
Design Therapeutics, Inc.盘中异动 急速下跌5.46%
Design Therapeutics, Inc.盘中异动 股价大跌5.62%报3.86美元
自选股智能写手 · 06-08
Design Therapeutics, Inc.盘中异动 股价大跌5.62%报3.86美元
Design Therapeutics, Inc.盘中异动 急速下挫5.46%
自选股智能写手 · 05-30
Design Therapeutics, Inc.盘中异动 急速下挫5.46%
Design Therapeutics, Inc.盘中异动 股价大涨5.58%
自选股智能写手 · 05-24
Design Therapeutics, Inc.盘中异动 股价大涨5.58%
Design Therapeutics, Inc.盘中异动 早盘股价大涨5.09%报4.93美元
自选股智能写手 · 05-08
Design Therapeutics, Inc.盘中异动 早盘股价大涨5.09%报4.93美元
Design Therapeutics, Inc.盘中异动 股价大涨7.67%
自选股智能写手 · 05-07
Design Therapeutics, Inc.盘中异动 股价大涨7.67%
暂无数据
公司概况
公司名称:
Design Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Design Therapeutics, Inc.于2017年12月18日根据特拉华州法律成立。他们是一家临床阶段的生物制药公司,开创了新的小分子治疗候选物,称为GeneTACs,旨在用于疾病治疗。某些核苷酸重复扩增疾病,如FA,可导致特异性mRNAs表达降低;在其他疾病,如强直性肌营养不良1型(DM1)、FECD和Huntington病,核苷酸重复扩增可导致毒性基因产物的产生,通常与病理性核病灶有关。他们的基因被设计成选择性地与基因重复序列结合,通过恢复或阻断mRNA转录来调节基因表达,并恢复细胞健康。作为一个平台,他们相信GeneTACs在单基因核苷酸重复序列扩增疾病中具有广泛的潜在适用性。
发行价格:
--
{"stockData":{"symbol":"DSGN","market":"US","secType":"STK","nameCN":"Design Therapeutics, Inc.","latestPrice":4.45,"timestamp":1723838400000,"preClose":4.29,"halted":0,"volume":82654,"hourTrading":{"tag":"盘后","latestPrice":4.45,"preClose":4.45,"latestTime":"16:02 EDT","volume":1361,"amount":6056.45,"timestamp":1723838562650},"delay":0,"floatShares":24420975,"shares":56620525,"eps":-0.89779,"marketStatus":"休市中","marketStatusCode":7,"change":0.16,"latestTime":"08-16 16:00:00 EDT","open":4.28,"high":4.54,"low":4.24,"amount":365957.387424,"amplitude":0.06993,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.89779,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724054400000},"adr":0,"listingDate":1616731200000,"adjPreClose":4.29,"postHourTrading":{"tag":"盘后","latestPrice":4.45,"preClose":4.45,"latestTime":"16:02 EDT","volume":1361,"amount":6056.45,"timestamp":1723838562650},"volumeRatio":0.3213175834612606,"impliedVol":1.7257,"impliedVolPercentile":0.7024},"requestUrl":"/m/hq/s/DSGN/tweets","defaultTab":"tweets","newsList":[{"id":"2460124242","title":"Design Therapeutics, Inc.盘中异动 下午盘股价大涨5.83%报4.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460124242","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460124242?lang=zh_cn&edition=full","pubTime":"2024-08-17 01:01","pubTimestamp":1723827663,"startTime":"0","endTime":"0","summary":"北京时间2024年08月17日01时01分,Design Therapeutics, Inc.股票出现波动,股价急速上涨5.83%。Design Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.25%。Design Therapeutics, Inc.公司简介:Design Therapeutics Inc是一家临床阶段的生物制药公司,致力于研究和开发 GeneTAC 分子,这是一种新型的针对特定基因的小分子嵌合体治疗候选物,旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081701010498e35341&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081701010498e35341&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","LENZ","BK4539","DSGN"],"gpt_icon":0},{"id":"2459547997","title":"Design Therapeutics, Inc.盘中异动 股价大涨5.45%报4.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459547997","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459547997?lang=zh_cn&edition=full","pubTime":"2024-08-15 22:57","pubTimestamp":1723733849,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日22时57分,Design Therapeutics, Inc.股票出现波动,股价大幅上涨5.45%。截至发稿,该股报4.45美元/股,成交量7283股,换手率0.01%,振幅2.61%。Design Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.73%。Design Therapeutics, Inc.公司简介:Design Therapeutics Inc是一家临床阶段的生物制药公司,致力于研究和开发 GeneTAC 分子,这是一种新型的针对特定基因的小分子嵌合体治疗候选物,旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815225730a1d47473&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815225730a1d47473&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","DSGN","LENZ","BK4539"],"gpt_icon":0},{"id":"2458518188","title":"Design Therapeutics, Inc.盘中异动 早盘快速上涨5.42%报4.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458518188","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458518188?lang=zh_cn&edition=full","pubTime":"2024-08-09 23:12","pubTimestamp":1723216336,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日23时12分,Design Therapeutics, Inc.股票出现异动,股价急速拉升5.42%。Design Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为2.56%。Design Therapeutics, Inc.公司简介:Design Therapeutics Inc是一家临床阶段的生物制药公司,致力于研究和开发 GeneTAC 分子,这是一种新型的针对特定基因的小分子嵌合体治疗候选物,旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809231216941ffc38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809231216941ffc38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","DSGN","BK4539","LENZ"],"gpt_icon":0},{"id":"2458328729","title":"Design Therapeutics, Inc.盘中异动 下午盘急速上涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458328729","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458328729?lang=zh_cn&edition=full","pubTime":"2024-08-09 02:20","pubTimestamp":1723141248,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日02时20分,Design Therapeutics, Inc.股票出现波动,股价大幅上涨5.33%。Design Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为3.91%。Design Therapeutics, Inc.公司简介:Design Therapeutics Inc是一家临床阶段的生物制药公司,致力于研究和开发 GeneTAC 分子,这是一种新型的针对特定基因的小分子嵌合体治疗候选物,旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809022048af96a3a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809022048af96a3a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","DSGN","BK4539","LENZ"],"gpt_icon":0},{"id":"2457405006","title":"Design Therapeutics公司:Leerink Partners将目标价从4.00美元上调至5.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457405006","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457405006?lang=zh_cn&edition=full","pubTime":"2024-08-06 12:38","pubTimestamp":1722919114,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["DSGN","BK4539","LENZ","BK4505","BK4139"],"gpt_icon":0},{"id":"2457018727","title":"Design Therapeutics(DSGN.US):2024年Q2财报实现营收0美元,前值为0美元;每股收益为-0.","url":"https://stock-news.laohu8.com/highlight/detail?id=2457018727","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457018727?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:19","pubTimestamp":1722863951,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["DSGN","BK4139","LENZ","BK4505","BK4539"],"gpt_icon":0},{"id":"2457729362","title":"Design Therapeutics:截至2024年6月30日的现金、现金等价物和可变现证券预计可支持其计划的营业费用直至2029年。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457729362","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457729362?lang=zh_cn&edition=full","pubTime":"2024-08-05 20:02","pubTimestamp":1722859362,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BK4505","DSGN","LENZ","161027","BK4539"],"gpt_icon":0},{"id":"2456284336","title":"Design Therapeutics, Inc.盘中异动 早盘股价大跌8.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456284336","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456284336?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:34","pubTimestamp":1722605648,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时34分,Design Therapeutics, Inc.股票出现波动,股价急速跳水8.12%。Design Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.59%。Design Therapeutics, Inc.公司简介:Design Therapeutics Inc是一家临床阶段的生物制药公司,致力于研究和开发 GeneTAC 分子,这是一种新型的针对特定基因的小分子嵌合体治疗候选物,旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080221340895780d9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080221340895780d9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DSGN","BK4505","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2454049778","title":"Design Therapeutics, Inc.盘中异动 快速上涨5.23%报5.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454049778","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454049778?lang=zh_cn&edition=full","pubTime":"2024-07-26 00:45","pubTimestamp":1721925915,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日00时45分,Design Therapeutics, Inc.股票出现波动,股价大幅上涨5.23%。Design Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.04%。Design Therapeutics, Inc.公司简介:Design Therapeutics Inc是一家临床阶段的生物制药公司,致力于研究和开发 GeneTAC 分子,这是一种新型的针对特定基因的小分子嵌合体治疗候选物,旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726004515af9422fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726004515af9422fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BK4505","DSGN","LENZ"],"gpt_icon":0},{"id":"2453884688","title":"Design Therapeutics, Inc.盘中异动 早盘急速拉升5.19%报4.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453884688","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453884688?lang=zh_cn&edition=full","pubTime":"2024-07-24 23:29","pubTimestamp":1721834988,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日23时29分,Design Therapeutics, Inc.股票出现异动,股价大幅上涨5.19%。Design Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.56%。Design Therapeutics, Inc.公司简介:Design Therapeutics Inc是一家临床阶段的生物制药公司,致力于研究和开发 GeneTAC 分子,这是一种新型的针对特定基因的小分子嵌合体治疗候选物,旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724232949aefb4287&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724232949aefb4287&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","DSGN","BK4139","BK4505"],"gpt_icon":0},{"id":"2452439071","title":"Design Therapeutics, Inc.盘中异动 临近午盘股价大跌5.38%报4.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452439071","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452439071?lang=zh_cn&edition=full","pubTime":"2024-07-18 23:57","pubTimestamp":1721318221,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日23时57分,Design Therapeutics, Inc.股票出现异动,股价快速下跌5.38%。截至发稿,该股报4.22美元/股,成交量1.2065万股,换手率0.02%,振幅4.04%。Design Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为2.17%。Design Therapeutics, Inc.公司简介:Design Therapeutics Inc是一家临床阶段的生物制药公司,致力于研究和开发 GeneTAC 分子,这是一种新型的针对特定基因的小分子嵌合体治疗候选物,旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718235702941f8601&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718235702941f8601&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4539","BK4505","DSGN"],"gpt_icon":0},{"id":"2451915231","title":"Design Therapeutics, Inc.盘中异动 股价大涨5.02%报4.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451915231","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451915231?lang=zh_cn&edition=full","pubTime":"2024-07-16 22:28","pubTimestamp":1721140128,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日22时28分,Design Therapeutics, Inc.股票出现波动,股价急速拉升5.02%。Design Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.88%。Design Therapeutics, Inc.公司简介:Design Therapeutics Inc是一家临床阶段的生物制药公司,致力于研究和开发 GeneTAC 分子,这是一种新型的针对特定基因的小分子嵌合体治疗候选物,旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162228489681d367&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162228489681d367&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DSGN","BK4505","LENZ","BK4539","BK4139"],"gpt_icon":0},{"id":"2450539873","title":"Design Therapeutics, Inc.盘中异动 早盘快速上涨5.66%报4.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450539873","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450539873?lang=zh_cn&edition=full","pubTime":"2024-07-12 22:00","pubTimestamp":1720792809,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日22时00分,Design Therapeutics, Inc.股票出现波动,股价快速上涨5.66%。Design Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.23%。Design Therapeutics, Inc.公司简介:Design Therapeutics Inc是一家临床阶段的生物制药公司,致力于研究和开发 GeneTAC 分子,这是一种新型的针对特定基因的小分子嵌合体治疗候选物,旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712220009af921dfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712220009af921dfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DSGN","BK4539","BK4505","LENZ"],"gpt_icon":0},{"id":"2450637753","title":"Design Therapeutics, Inc.盘中异动 股价大涨5.25%报3.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450637753","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450637753?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:00","pubTimestamp":1720706409,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日22时00分,Design Therapeutics, Inc.股票出现波动,股价快速上涨5.25%。Design Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.85%。Design Therapeutics, Inc.公司简介:Design Therapeutics Inc是一家临床阶段的生物制药公司,致力于研究和开发 GeneTAC 分子,这是一种新型的针对特定基因的小分子嵌合体治疗候选物,旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711220009941f6480&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711220009941f6480&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","LENZ","BK4539","DSGN"],"gpt_icon":0},{"id":"2443059934","title":"Design Therapeutics, Inc.盘中异动 急速下跌5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443059934","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2443059934?lang=zh_cn&edition=full","pubTime":"2024-06-13 03:25","pubTimestamp":1718220328,"startTime":"0","endTime":"0","summary":"北京时间2024年06月13日03时25分,Design Therapeutics, Inc.股票出现异动,股价急速跳水5.46%。Design Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.73%。Design Therapeutics, Inc.公司简介:Design Therapeutics Inc是一家临床阶段的生物制药公司,致力于研究和开发 GeneTAC 分子,这是一种新型的针对特定基因的小分子嵌合体治疗候选物,旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240613032529aef49dc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240613032529aef49dc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4505","BK4139","DSGN","LENZ"],"gpt_icon":0},{"id":"2441094146","title":"Design Therapeutics, Inc.盘中异动 股价大跌5.62%报3.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441094146","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441094146?lang=zh_cn&edition=full","pubTime":"2024-06-08 02:11","pubTimestamp":1717783911,"startTime":"0","endTime":"0","summary":"北京时间2024年06月08日02时11分,Design Therapeutics, Inc.股票出现异动,股价急速跳水5.62%。Design Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.32%。Design Therapeutics, Inc.公司简介:Design Therapeutics Inc是一家临床阶段的生物制药公司,致力于研究和开发 GeneTAC 分子,这是一种新型的针对特定基因的小分子嵌合体治疗候选物,旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240608021151af8cae53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240608021151af8cae53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DSGN","BK4539","BK4505","LENZ"],"gpt_icon":0},{"id":"2439505301","title":"Design Therapeutics, Inc.盘中异动 急速下挫5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439505301","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439505301?lang=zh_cn&edition=full","pubTime":"2024-05-30 01:25","pubTimestamp":1717003530,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日01时25分,Design Therapeutics, Inc.股票出现异动,股价急速跳水5.46%。Design Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.85%。Design Therapeutics, Inc.公司简介:Design Therapeutics Inc是一家临床阶段的生物制药公司,致力于研究和开发 GeneTAC 分子,这是一种新型的针对特定基因的小分子嵌合体治疗候选物,旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530012530af8af202&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530012530af8af202&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4539","DSGN","BK4505"],"gpt_icon":0},{"id":"2437303021","title":"Design Therapeutics, Inc.盘中异动 股价大涨5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437303021","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437303021?lang=zh_cn&edition=full","pubTime":"2024-05-24 21:37","pubTimestamp":1716557872,"startTime":"0","endTime":"0","summary":"北京时间2024年05月24日21时37分,Design Therapeutics, Inc.股票出现波动,股价大幅拉升5.58%。Design Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.06%。Design Therapeutics, Inc.公司简介:Design Therapeutics Inc是一家临床阶段的生物制药公司,致力于研究和开发 GeneTAC 分子,这是一种新型的针对特定基因的小分子嵌合体治疗候选物,旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240524213752aef19540&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240524213752aef19540&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","DSGN","BK4139","BK4505"],"gpt_icon":0},{"id":"2433722854","title":"Design Therapeutics, Inc.盘中异动 早盘股价大涨5.09%报4.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433722854","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433722854?lang=zh_cn&edition=full","pubTime":"2024-05-08 21:51","pubTimestamp":1715176298,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日21时51分,Design Therapeutics, Inc.股票出现波动,股价急速上涨5.09%。Design Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.43%。Design Therapeutics, Inc.公司简介:Design Therapeutics Inc是一家临床阶段的生物制药公司,致力于研究和开发 GeneTAC 分子,这是一种新型的针对特定基因的小分子嵌合体治疗候选物,旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。消息层面,截至21时51分,Design Therapeutics, Inc.股票正面舆情新闻比例50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508215138861ebc8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508215138861ebc8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","DSGN","BK4139","BK4539"],"gpt_icon":0},{"id":"2433200822","title":"Design Therapeutics, Inc.盘中异动 股价大涨7.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433200822","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433200822?lang=zh_cn&edition=full","pubTime":"2024-05-07 21:32","pubTimestamp":1715088769,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日21时32分,Design Therapeutics, Inc.股票出现异动,股价快速上涨7.67%。Design Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.72%。Design Therapeutics, Inc.公司简介:Design Therapeutics Inc是一家临床阶段的生物制药公司,致力于研究和开发 GeneTAC 分子,这是一种新型的针对特定基因的小分子嵌合体治疗候选物,旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。消息层面,截至21时32分,Design Therapeutics, Inc.股票正面舆情新闻比例100%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050721324987dc9e4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050721324987dc9e4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DSGN","BK4539","BK4505","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.designtx.com","stockEarnings":[{"period":"1week","weight":0.0495},{"period":"1month","weight":-0.0022},{"period":"3month","weight":0.0091},{"period":"6month","weight":0.692},{"period":"1year","weight":1.0991},{"period":"ytd","weight":0.6792}],"compareEarnings":[{"period":"1week","weight":0.04},{"period":"1month","weight":-0.0047},{"period":"3month","weight":0.047},{"period":"6month","weight":0.1097},{"period":"1year","weight":0.2705},{"period":"ytd","weight":0.1662}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Design Therapeutics, Inc.于2017年12月18日根据特拉华州法律成立。他们是一家临床阶段的生物制药公司,开创了新的小分子治疗候选物,称为GeneTACs,旨在用于疾病治疗。某些核苷酸重复扩增疾病,如FA,可导致特异性mRNAs表达降低;在其他疾病,如强直性肌营养不良1型(DM1)、FECD和Huntington病,核苷酸重复扩增可导致毒性基因产物的产生,通常与病理性核病灶有关。他们的基因被设计成选择性地与基因重复序列结合,通过恢复或阻断mRNA转录来调节基因表达,并恢复细胞健康。作为一个平台,他们相信GeneTACs在单基因核苷酸重复序列扩增疾病中具有广泛的潜在适用性。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.250058},{"month":2,"riseRate":0.666667,"avgChangeRate":0.04907},{"month":3,"riseRate":0.666667,"avgChangeRate":0.151963},{"month":4,"riseRate":0.25,"avgChangeRate":-0.098031},{"month":5,"riseRate":0.5,"avgChangeRate":0.01688},{"month":6,"riseRate":0.5,"avgChangeRate":-0.04322},{"month":7,"riseRate":0.75,"avgChangeRate":0.24854},{"month":8,"riseRate":0.5,"avgChangeRate":-0.193665},{"month":9,"riseRate":0,"avgChangeRate":-0.096213},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.044663},{"month":11,"riseRate":0.666667,"avgChangeRate":0.046787},{"month":12,"riseRate":0.666667,"avgChangeRate":0.038666}],"exchange":"NASDAQ","name":"Design Therapeutics, Inc.","nameEN":"Design Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Design Therapeutics, Inc.(DSGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Design Therapeutics, Inc.(DSGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Design Therapeutics, Inc.,DSGN,Design Therapeutics, Inc.股票,Design Therapeutics, Inc.股票老虎,Design Therapeutics, Inc.股票老虎国际,Design Therapeutics, Inc.行情,Design Therapeutics, Inc.股票行情,Design Therapeutics, Inc.股价,Design Therapeutics, Inc.股市,Design Therapeutics, Inc.股票价格,Design Therapeutics, Inc.股票交易,Design Therapeutics, Inc.股票购买,Design Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Design Therapeutics, Inc.(DSGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Design Therapeutics, Inc.(DSGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}